Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA SUVEN LIFE SCIENCES ELDER PHARMA/
SUVEN LIFE SCIENCES
 
P/E (TTM) x -1.0 -20.8 - View Chart
P/BV x 0.1 5.9 1.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ELDER PHARMA   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
SUVEN LIFE SCIENCES
Mar-23
ELDER PHARMA/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs38094 405.3%   
Low Rs18845 417.7%   
Sales per share (Unadj.) Rs489.20.6 78,792.8%  
Earnings per share (Unadj.) Rs-3.2-5.4 58.6%  
Cash flow per share (Unadj.) Rs14.4-5.1 -281.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs376.517.2 2,187.6%  
Shares outstanding (eoy) m20.54218.07 9.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.6111.8 0.5%   
Avg P/E ratio x-89.3-12.8 698.0%  
P/CF ratio (eoy) x19.7-13.5 -145.5%  
Price / Book Value ratio x0.84.0 18.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,83215,131 38.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2,179186 1,170.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,048135 7,421.5%  
Other income Rs m25784 303.7%   
Total revenues Rs m10,305220 4,686.4%   
Gross profit Rs m2,921-1,196 -244.1%  
Depreciation Rs m36165 552.1%   
Interest Rs m2,7565 51,232.5%   
Profit before tax Rs m60-1,183 -5.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1250-   
Profit after tax Rs m-65-1,183 5.5%  
Gross profit margin %29.1-883.6 -3.3%  
Effective tax rate %209.10-   
Net profit margin %-0.6-873.5 0.1%  
BALANCE SHEET DATA
Current assets Rs m9,2403,455 267.5%   
Current liabilities Rs m9,9981,050 951.9%   
Net working cap to sales %-7.51,776.0 -0.4%  
Current ratio x0.93.3 28.1%  
Inventory Days Days1283,948 3.2%  
Debtors Days Days602218 276.5%  
Net fixed assets Rs m13,6421,373 993.4%   
Share capital Rs m206218 94.3%   
"Free" reserves Rs m7,5283,535 212.9%   
Net worth Rs m7,7333,753 206.1%   
Long term debt Rs m4,8890-   
Total assets Rs m22,8824,828 473.9%  
Interest coverage x1.0-218.8 -0.5%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.40 1,565.9%   
Return on assets %11.8-24.4 -48.2%  
Return on equity %-0.8-31.5 2.7%  
Return on capital %22.3-31.4 -71.1%  
Exports to sales %3.140.4 7.5%   
Imports to sales %0.4839.8 0.1%   
Exports (fob) Rs m30755 560.0%   
Imports (cif) Rs m431,137 3.8%   
Fx inflow Rs m30755 560.0%   
Fx outflow Rs m1251,137 11.0%   
Net fx Rs m181-1,082 -16.8%   
CASH FLOW
From Operations Rs m11,754-1,031 -1,139.5%  
From Investments Rs m-561-2,606 21.5%  
From Financial Activity Rs m-6,7623,955 -171.0%  
Net Cashflow Rs m5,466317 1,721.8%  

Share Holding

Indian Promoters % 25.3 69.6 36.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 24.0 0.6 4,360.0%  
FIIs % 0.0 0.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 74.7 30.4 245.3%  
Shareholders   31,548 74,003 42.6%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Elder Pharma vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Elder Pharma vs Suven Life Sciences Share Price Performance

Period Elder Pharma Suven Life Sciences S&P BSE HEALTHCARE
1-Day 4.97% -2.13% -0.95%
1-Month 21.21% -9.05% -5.00%
1-Year -64.54% 110.43% 57.49%
3-Year CAGR -51.65% 13.58% 18.15%
5-Year CAGR -37.46% -15.49% 18.88%

* Compound Annual Growth Rate

Here are more details on the Elder Pharma share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of Elder Pharma hold a 25.3% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Elder Pharma and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, Elder Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Elder Pharma, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.